Skip to main content

Peer Review reports

From: Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma

Original Submission
10 Mar 2022 Submitted Original manuscript
24 Apr 2022 Reviewed Reviewer Report
25 Apr 2022 Reviewed Reviewer Report
8 May 2022 Author responded Author comments - Rui Zhang
Resubmission - Version 2
8 May 2022 Submitted Manuscript version 2
12 May 2022 Author responded Author comments - Rui Zhang
Resubmission - Version 3
12 May 2022 Submitted Manuscript version 3
24 May 2022 Reviewed Reviewer Report
24 May 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 May 2022 Editorially accepted
8 Jun 2022 Article published 10.1186/s12885-022-09696-w

You can find further information about peer review here.

Back to article page